You can buy or sell ATHE and other stocks, options, ETFs, and crypto commission-free!
Alterity Therapeutics Ltd. engages in the development of therapeutic drugs designed to treat the underlying causes of degeneration of the brain as the aging process progresses. It focuses on Parkinson's movement disorders, Alzheimer's disease, Huntington disease, and other neurodegenerative disorders. Read More The company was founded by Geoffrey Paul Kempler on November 11, 1997 and is headquartered in Melbourne, Australia. The listed name for ATHE is Alterity Therapeutics Limited American Depositary Shares.
Melbourne, Victoria (VIC)
52 Week High
52 Week Low
— per share